CBC Cannabichromene
Grades as of 9 August 2026 · check cbgatlas.com/card/cbc
Specimen
- Formula
- C₂₁H₃₀O₂
- Molar mass
- ≈ 314.46 g/mol
- Class
- Cannabinoid, from the CBCA branch
- Intoxicating
- No
- Evidence base
- Catalogue in progress: no CBC record in our registry yet
- CAS
- 20675-51-8
- Studies in our registry
- 0 · catalogue in progress
In the family
Also non-intoxicating, with a pharmacology still being catalogued; one of the three branches off the shared CBGA substrate.
The record cited in prose · ungraded
Established
- Chemical identity C₂₁H₃₀O₂, molar mass ≈ 314.46 g/mol.
- One of three branches off a single substrate CBCA synthase converts the shared CBGa substrate into CBCA, which decarboxylates to CBC.
- Characterised at TRPA1, and inactive at several other channels In laboratory assays CBC acts at TRPA1 and inhibits anandamide cellular uptake.
Not yet established
- Any controlled human trial of isolated CBC The published work cited here stops at cells and rodents, and none of it establishes an effect in a person.
- Which target carries the effect in a living animal In recombinant cells CBC behaves as a low-potency CB2 agonist with little CB1 activity.
- A CBC record in our evidence registry Until one is added, the CBC filter in the Research Library reads zero rather than sitting blank.
Cardiovascular note grade: grade: Hypothesized
CBG may influence blood pressure via α2-adrenoceptor activity; the direction and magnitude of any human effect are uncharacterized. Mechanistic plausibility only: the receptor activity has been measured in the laboratory, and no study has measured a blood-pressure effect of CBG in a person. A CBG finding, printed here because CBC shares the family; it does not transfer to CBC. If you take blood-pressure medication or have a cardiovascular condition, consult a clinician first.
Informational only, not medical advice. Nothing here diagnoses, treats, cures or prevents any disease. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.